Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 07:09:53 +0200Wed, 12 Jun 2024 14:11:00 +0200Human medicines European public assessment report (EPAR): Aubagio, teriflunomide, Date of authorisation: 26/08/2013, Revision: 27, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/aubagioHuman medicines European public assessment report (EPAR): Aubagio, teriflunomide, Date of authorisation: 26/08/2013, Revision: 27, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/aubagioWed, 12 Jun 2024 14:11:00 +0200Human medicineAubagio-H-C-PSUSA-00010135-201409 : EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisationhttps://www.ema.europa.eu/system/files/documents/scientific-conclusion/wc500191116_en.pdfAubagio-H-C-PSUSA-00010135-201409 : EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisationhttps://www.ema.europa.eu/system/files/documents/scientific-conclusion/wc500191116_en.pdfThu, 30 Jul 2015 02:00:00 +0200Human medicine